Package Insert: Information for the User
dexketoprofen
6. Contents of the pack and additional information
Enantyumis a pain reliever belonging to thegroup ofmedicines known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is used for the short-term symptomatic treatment of mild to moderate acute pain, such as acute muscle pain or joint pain, menstrual pain (dysmenorrhea), toothache.
Do not take Enantyum
-If you are allergic to dexketoprofen or any of the other components of this medication (listed in section 6);
-If you are allergic to acetylsalicylic acid or another nonsteroidal anti-inflammatory drug;
-If you have asthma or have had asthma attacks, acute allergic rhinitis (a short period of nasal mucosa inflammation), nasal polyps (fleshy formations in the nasal cavity due to allergy), urticaria (skin eruption), angioedema (face, eye, lip, or tongue swelling, or difficulty breathing), or chest wheezing after taking acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs;
-If you have had photoallergic or phototoxic reactions (a special form of skin redness or burns exposed to sunlight) during the use of ketoprofen (a nonsteroidal anti-inflammatory drug) or fibrates (medications used to reduce blood lipid levels);
-If you have chronic inflammatory bowel disease (Crohn's disease or ulcerative colitis);
-If you have severe heart failure, moderate to severe renal insufficiency, or severe liver insufficiency;
-If you have bleeding disorders or blood clotting disorders;
-If you are severely dehydrated (have lost a lot of body fluid) due to vomiting, diarrhea, or inadequate fluid intake;
-If you are in the third trimester of pregnancy or breastfeeding;
Warnings and precautions
Consult your doctor or pharmacist before starting to take Enantyum:
-If you are allergic or have had allergic reactions in the past;
-If you have kidney, liver, or heart diseases (hypertension and/or heart failure), or have had these conditions in the past;
-If you are taking diuretics or have inadequate hydration and reduced blood volume due to excessive fluid loss (for example, excessive urination, diarrhea, or vomiting);
-If you have heart problems, a history of strokes, or think you may be at risk of these conditions (for example, high blood pressure, diabetes, high cholesterol, or smoking) consult this treatment with your doctor or pharmacist. Enantyum medications may be associated with a small increase in the risk of heart attacks ("myocardial infarction") or strokes ("cerebrovascular accident"). This risk is more likely to occur when high doses and prolonged treatments are used. Do not exceed the recommended dose or treatment duration;
-If you are elderly, you may be more likely to experience adverse effects (see section 4). If these occur, consult your doctor immediately;
-If you are a woman with fertility problems (Enantyum may reduce your fertility, so do not take it if you are planning to become pregnant or undergoing fertility studies);
-If you have a disorder in blood and blood cell production;
-If you have systemic lupus erythematosus or mixed connective tissue disease (autoimmune diseases that affect connective tissue);
-If you have had or have had chronic inflammatory bowel disease (ulcerative colitis, Crohn's disease);
-If you have had or have had gastrointestinal or intestinal disorders;
-If you have an infection; see the "Infections" heading below;
-If you are taking other medications that increase the risk of peptic ulcers or bleeding, for example, oral corticosteroids, some antidepressants (SSRI type), agents that prevent clot formation such as acetylsalicylic acid (aspirin) or anticoagulants like warfarin or acenocoumarol (Sintrom). In these cases, consult your doctor before taking Enantyum: your doctor may prescribe an additional medication to protect your stomach (for example, misoprostol or other medications that block stomach acid production).
-If you have asthma, combined with allergic rhinitis or chronic sinusitis, and/or nasal polyps, as you have a higher risk of being allergic to acetylsalicylic acid and/or NSAIDs than the general population. Administration of this medication may cause asthma attacks or bronchospasm, particularly in patients allergic to acetylsalicylic acid or NSAIDs.
Infections
Enantyum may mask the signs of an infection, such as fever and pain. Therefore, it is possible that Enantyum may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in pneumonia caused by bacteria and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the infection symptoms persist or worsen, consult a doctor without delay.
During chickenpox, it is recommended to avoid using this medication.
Children and adolescents
Enantyum has not been studied in children or adolescents. Therefore, safety and efficacy have not been established, and the product should not be used in children or adolescents.
Taking Enantyum with other medications
Inform your doctor or pharmacist if you are taking or have taken recently or may need to take any other medication, including those purchased without a prescription. There are some medications that should not be taken together, and other medications that may require a dose change when taken together.
Inform your doctor, dentist, or pharmacist if, in addition to Enantyum, you are using or being administered any of the following medications:
Non-recommended associations:
-Acetylsalicylic acid, corticosteroids, and other anti-inflammatory drugs;
-Warfarin or acenocoumarol (Sintrom), heparin, or other medications used to prevent clot formation;
-Lithium, used to treat mood disorders;
-Metotrexate (cancer medication and immunosuppressant), used at high doses of 15mg/week;
-Hidantoins and phenytoin, used for epilepsy;
-Sulfamethoxazole, used for bacterial infections;
Associations requiring caution:
-Inhibitors of the ECA, diuretics, and angiotensin II antagonists, used for high blood pressure and heart conditions;
-Pentoxifylline and oxpentifylline, used to treat chronic venous ulcers;
-Zidovudine, used to treat viral infections;
- Aminoglycoside antibiotics, used for bacterial infections;
-Sulfonilureas (e.g. chlorpropamide and glibenclamide), used for diabetes;
-Metotrexate, used at low doses, less than 15mg/week.
Associations to be taken into account:
-Quinolones (e.g. ciprofloxacin, levofloxacin), used for bacterial infections;
-Ciclosporin or tacrolimus, used to treat autoimmune diseases and organ transplants;
-Streptokinase and other thrombolytic and fibrinolytic medications; that is, medications used to break down clots;
-Probenecid, used for gout;
-Digoxin, used in the treatment of chronic heart failure;
-Mifepristone, used as an abortifacient (to interrupt pregnancy);
-SSRI-type antidepressants;
-Antiplatelet agents used to reduce platelet aggregation and clot formation;
-Beta-blockers, used for high blood pressure and heart conditions.
-Tenofovir, deferasirox, pemetrexed.
If you have any doubts about taking other medications with Enantyum, consult your doctor or pharmacist.
Enantyum with food and drinks
Take the capsules with an empty stomach; that is, at least 15 minutes before meals, as this will facilitate the medication's action a little faster.
Pregnancy, breastfeeding, and fertility
Do not take Enantyum during the last three months of pregnancy or while breastfeeding. It may cause kidney and heart problems in your fetus. It may affect your predisposition and that of your baby to bleed and delay or prolong delivery more than expected.
Do not take Enantyum during the first six months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time. From week 20 of pregnancy, Enantyum may cause kidney problems in your fetus if taken for more than a few days, which may cause low amniotic fluid levels surrounding the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional monitoring.
Enantyum is not recommended for use while trying to conceive or while studying fertility problems.
Regarding potential effects on female fertility, see also section 2, "Warnings and precautions".
Driving and operating machinery
Enantyum may slightly affect your ability to drive and operate machinery, as it may cause drowsiness, dizziness, and blurred vision as adverse effects of treatment. If you notice these effects, do not use machinery or drive until these symptoms disappear. Consult your doctor.
Enantyum contains saccharose
If your doctor has indicated that you have an intolerance to certain sugars, consult with him before taking this medication.
It contains 2,418 g of saccharose per dose, which should be taken into account in patients with diabetes mellitus.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
The effective dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult a doctor immediately if symptoms (such as fever and pain) persist or worsen (see section 2).
Adults 18 years of age and older
The dose of Enantyum you need may vary, depending on the type, intensity, and duration of pain. Your doctor will tell you how many packets to take per day and for how long.
The recommended dose is 1 packet (25 mg) every 8 hours, not exceeding 3 packets per day (75 mg).
If you are elderly or have kidney or liver disease, it is recommended to start therapy with a maximum of 2 packets per day (50 mg).
In elderly patients, this initial dose may be increased later according to the general recommended dose (75 mg of dexketoprofen) if Enantyum has been well tolerated.
If your pain is intense and you need quick relief, take the packets on an empty stomach (at least 15 minutes before eating) as they will be absorbed more easily (see section 2 “Enantyum with food and drinks”).
Use in children and adolescents
This medication should not be used in children and adolescents (under 18 years of age).
Instructions for proper use
Dissolve the entire contents of a packet in a glass of water; agitate/shake to help dissolve. The resulting solution should be taken immediately after reconstitution.
If you take more Enantyum than you should
Consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91.562.04.20, indicating the medication and the amount taken. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forgot to take Enantyum
Do not take a double dose to make up for the missed doses. Take the next dose when due (according to section 3 “How to take Enantyum”).
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The possible side effects are listed below according to their frequency. Since the list is based in part on the side effects observed with the use of Enantyum tablets, and since Enantyum granules are absorbed faster than tablets, it is possible that the actual frequency of side effects (gastrointestinal) may be higher with Enantyum granules.
Frequent side effects: may affect up to 1 in 10 people
Nausea and/or vomiting, mainly upper abdominal pain, diarrhea, digestive disorders (dyspepsia).
Less frequent side effects: may affect up to 1 in 100 people
Dizziness (vertigo), dizziness, drowsiness, sleep disorders, nervousness, headache, palpitations, hot flashes, stomach wall inflammation (gastritis), constipation, dry mouth, flatulence, skin rash, fatigue, pain, feverish sensation and chills, general discomfort.
Rare side effects: may affect up to 1 in 1,000 people
Peptic ulcer, perforation of peptic ulcer or bleeding (which may manifest with vomiting blood or black stools), fainting, high blood pressure, slow breathing, fluid retention and peripheral swelling (e.g. swelling of ankles), laryngeal edema, loss of appetite (anorexia), abnormal sensation, pruritic rash, acne, increased sweating, lower back pain, frequent urination, menstrual disorders, prostate disorders, abnormal liver function tests (blood tests), liver cell damage (hepatitis), acute renal insufficiency.
Very rare: may affect up to 1 in 10,000 people
Anaphylactic reaction (hypersensitivity reaction that can also lead to collapse), skin ulcers, mouth, eyes, and genital areas (Stevens-Johnson syndrome and Lyell syndrome), facial swelling or lip and throat swelling (angioedema), difficulty breathing due to narrowing of airways (bronchospasm), lack of air, tachycardia, low blood pressure, pancreatitis inflammation, blurred vision, ringing in the ears (tinnitus), sensitive skin, light sensitivity, itching, kidney problems. Decreased white blood cell count (neutropenia), decreased platelet count (thrombocytopenia).
Inform your doctor immediately if you notice any gastrointestinal side effects at the start of treatment (e.g. stomach pain or burning, or bleeding), if you have previously experienced any of these side effects due to prolonged treatment with anti-inflammatory drugs, and especially if you are elderly.
Stop taking Enantyum immediately if you notice the appearance of a skin rash or any lesions inside the mouth or on the genitals, or any other sign of allergy.
During treatment with non-steroidal anti-inflammatory drugs, cases of fluid retention and swelling (especially in ankles and legs), increased blood pressure, and heart failure have been reported.
Medicines like Enantyum may be associated with a small increase in the risk of suffering a heart attack ("myocardial infarction") or a stroke ("cerebral infarction").
In patients with autoimmune disorders affecting connective tissue (systemic lupus erythematosus or mixed connective tissue disease), anti-inflammatory drugs may rarely cause fever, headache, and neck stiffness.
The most commonly observed side effects are of a gastrointestinal nature. They may cause peptic ulcers, perforation or gastrointestinal bleeding, sometimes fatal, especially in elderly patients.
After administration, nausea, vomiting, diarrhea, flatulence, constipation, dyspepsia, abdominal pain, melena, hematemesis, ulcerative stomatitis, worsening of colitis and Crohn's disease have been reported. Less frequently, gastric wall inflammation (gastritis) has been observed.
Like other NSAIDs, anaphylactic reactions may occur.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of sight and out of reach of children.
Do not use this medication after the expiration date that appears on the packaging and on the label. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medications should not be disposed of through drains or in the trash. Deposit empty packaging and unused medications at the SIGRE point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of unused packaging and medications. This will help protect the environment.
Composition of Enantyum
Appearance of the product and contents of the packaging
Sachets containing a yellow lemon-colored granulate.
Enantyum 25 mg is available in packaging of 2, 4, 10, 20, 30, 40, 50, 100, and 500 sachets.
Not all packaging sizes may be marketed.
Holder of the marketing authorization and responsible manufacturer
LABORATORIOS MENARINI, S.A.
Alfons XII, 587 - Badalona (Barcelona) Spain
This medicine is authorized in the member states of the European Economic Area with the following names:
Hungary, Italy, Spain: Enantyum
Estonia, Latvia, Lithuania: Ketesse
Greece: Viaxal
Poland: Ketesse SL
Last review date of this leaflet:November 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.es/.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.